Zensun Got New Investment to Accelerate Phase III Clinical Trial of rhNRG-1

In 2009, Zensun's anti-heart failure drug -- rhNRG-1 successfully finished Chinese phase II clinical trials and was approved to take US phase II clinical trials. At the same time, the proceeding drug development also achieved significant progress.

The release as fetched from its publisher. zensun.com ↗